Premier Therapy.* Premium Platform.** Precise Relief.
Abbott offers the only systems that are FDA-approved to stimulate the dorsal root ganglion (DRG), an effective therapy that provides precise relief* for patients suffering from causalgia or CRPS of the lower limbs.1,2
The Proclaim™ DRG neurostimulation system provides clinically superior2 therapy on a platform designed for patients’ convenience.
The intense focal pain associated with causalgia and CRPS of the lower limbs, can often be attributed to nerve damage following an injury or surgical procedure. Examples of these conditions in the groin, hip, knee, ankle or foot leading to chronic pain may include the following:
- A suspected ilioinguinal or genitofemoral nerve injury following a hernia repair or vasectomy
- Abdominal surgery
- Total joint arthroplasties
- Limb amputation
- A surgery or traumatic injury of the hip, knee, ankle or foot
Advanced neurostimulation technologies
The Proclaim DRG neurostimulation system comes on a premium platform that includes Invisible Therapy™, a system offering discreet and patient-friendly Bluetooth® wireless technology and Apple‡ mobile digital programming. A range of other features enhance patient convenience, so they can focus on their lives and not on pain.
Longer battery life
The Proclaim DRG neurostimulation system offers a battery life of approximately 6.5 years at nominal settings3 potentially increasing the time between battery replacements and reducing the number of procedures and replacement devices.
Upgradable technology—only from Abbott—allows patients to benefit from advancements without surgery. As new technologies are approved, patients can receive software upgrades, easily and painlessly.
The Proclaim DRG neurostimulation system lets patients and clinicians use wireless programming with convenient and familiar technology. Patients can use the Apple‡ iPod‡ controller to:
- Turn stimulation on and off
- Adjust stimulation settings
- Cycle through programs
- Assess IPG battery longevity
Clinicians can use the clinician programmer, featuring an Apple‡ iPad mini‡ mobile digital device and downloadable programming app, to set programming parameters.
The Proclaim DRG neurostimulation system is MR Conditional, allowing scans of the head and extremities within approved MRI parameters.
DRG stimulation: A clinically proven therapy
DRG stimulation’s effectiveness has been proven in the ACCURATE study, the largest2 randomized clinical trial that compares traditional tonic SCS with DRG stimulation, to manage causalgia and CRPS in the lower limbs. It has been clinically proven to:
- Provide superior pain relief over traditional tonic SCS from causalgia and CRPS2
- Provide persistent pain relief to 86% of patients at 12 months2
- Reduce pain on average of 81.4% at 12 months2
See more clinical evidence.
St. Jude Medical™ Invisible Trial System with DRG Stimulation
The St. Jude Medical™ Invisible Trial System with DRG Stimulation is designed to closely mimic a permanent implant and provides an intuitive way for you and your patients to evaluate whether DRG stimulation is effective for them. Learn more about the St. Jude Medical™ Invisible Trial System with DRG Stimulation.
The Choice For Better Outcomes*
Deliver precise relief to your focal chronic pain patients with the Proclaim DRG neurostimulation system—the choice for achieving superior outcomes* and positive patient experience.
Read more about our approach to chronic pain management.